References
- Popovich R P, Moncrief J W, Decherd J F, Bomar J B, Pyle W K. The definition of a novel portable/wearable equilibrium peritoneal dialysis technique. Abstracts of ASAIO 1976; 5: 64
- Nolph K D, Boen F ST, Farrel P C, Pyle K W. Continuous ambulatory peritoneal dialysis in Australia, Europe and the United States: 1981. Kidney Int 1983; 23: 3–8
- Chan M K, Chuah P, Raftery M, Baillod R A, Sweny P, Varghese Z, Moorhead J F. Three years' experience of continuous ambulatory peritoneal dialysis. Lancet 1981; 1: 1409–12
- Oreopoulos D G, Robson M, Izatt S, Clayton S, de Veber G A. A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 1978; 24: 484–489
- Kramer P, Broyer M, Brunner F P, Brynger H, Donckerwolcke R A, Jacobs C, Selwood N H, Wing A J. Combined report on regular dialysis and transplantation in Europe, XII, 1981. Proc European Dialysis and Transplant Association. 1982
- Fenton S, Wu G, Cattran D, Wadgymar A, Allien A F. Clinical aspects of peritonitis in patients on CAPD. Peritoneal Dialysis Bull 1981; 1: 4–7, (Suppl.)
- Knight K R, Polak A. Laboratory diagnosis and oral treatment of CAPD peritonitis. Lancet 1982; 2: 1301–1304
- Lempert K D, Jones J M. Flucytosine-miconazole treatment of Candida peritonitis. Its use during continuous ambulatory peritoneal dialysis. Arch Intern Med 1982; 142: 577–578
- Gokal R, Ramos J M, Ward M K, Kerr D NS. “Eosinophilic” peritonitis in continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1981; 15: 328–330
- Leung A CT, Orange G, Henderson I S. Intraperitoneal hydrocortisone in eosinophilic peritonitis associated with continuous ambulatory peritoneal dialysis. Br Med J 1983; 286: 766
- Oreopoulos D G, Zellerman G, Izatt S. The Toronto Western Hospital permanent peritoneal catheter and continuous ambulatory peritoneal dialysis connector. Continuous ambulatory peritoneal dialysis, M Legrain. Excerpta Medica, Elsevier. 1980; 73–78, Proc of International Symposium Paris, Nov. 2–3
- Blumenkrantz M J, Gallagher N, Bashore A, Tenckhoff H. Retrograde menstruation in women undergoing chronic peritoneal dialysis. Obstet Gynecol 1981; 547: 667
- Colton T. Longitudinal studies and the use of the life table. Statistics in medicine. Little, Brown & Co., Boston 1974; 237–250, chapter 9
- Williams P, Khanna R, Oreopoulos D G. Treatment of peritonitis in patients on CAPD: No longer a controversy. Dialysis Transpl 1981; 10: 272–273
- Williams P, Khanna R, Vas S I, Oreopoulos D G, Layne S, Pantalony D. Treatment of peritonitis in patients on CAPD: To lavage or not?. Peritoneal Dialysis Bull 1980; 1: 14–17
- Blumenkrantz M J, Gahl G M, Kopple J D, Kamdar A V, Jones M R, Kessel M, Coburn J W. Protein losses during peritoneal dialysis. Kidney Int 1981; 19: 593–602
- Smeby L C, Wideroe T-E, Svartas T M, Jørstad S. Changes in water removal due to peritonitis during continuous peritoneal dialysis. Advances in peritoneal dialysis, G M Gahl, M Kessel, K D Nolph. Excerpta Medica, Amsterdam 1981; 287–292
- Nolph K D, Prowant B, Sorkin M T, Gloor H. The incidence and characteristics of peritonitis in the fourth year of a continuous ambulatory peritoneal dialysis program. Peritoneal Dialysis Bull 1981; 1: 50–53
- Gokal R, Manos J, Walker C, Mallick N P. Peritonitis related to defective continuous ambulatory peritoneal dialysis equipment. Lancet 1982; 2: 383–383
- Vas S I, Low D E, Oreopoulos D G, Manuel M A, Saiphoo C S, Fíner C, Dombros N. Antibiotic prophylaxis in CAPD patients. Peritoneal dialysis, R C Atkins, N M Thomson, P C Farrell. Churchill Livingstone, Edinburgh 1981; 320–326
- Slingeneyer A, Mion C, Despaux E, Perez C, Duport J, Dansette A M. Use of bacteriologic filter in the prevention of peritonitis associated with peritoneal dialysis: long term clinical results in intermittent and continuous ambulatory peritoneal dialysis. Peritoneal dialysis, R C Atkins, N M Thomson, P C Farrell. Churchill Livingstone, Edinburgh 1981; 301–312
- Duwe A K, Vas S I, Weatherhead J W. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 20: 130–135